Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Macrophage migration inhibitory factor.

Elias Lolis1, Richard Bucala

  • 1Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA. elias.lolis@yale.edu

Expert Opinion on Therapeutic Targets
|April 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ACR Treatment Guidelines and Expert Opinion: The Continuum of Knowledge Guiding Clinical Decision-Making.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Hypoxia Induces Adaptive Lymphangiogenesis via Cd74 and Vegfr3 to Modulate Pulmonary Hypertension.

Circulation research·2026
Same author

CD74 deficiency protects against doxorubicin cardiotoxicity through RRM2-mediated regulation of ferroptosis.

Acta pharmaceutica Sinica. B·2026
Same author

Identification of Lupus Immune Complex-Driven Pathogenic Pro-inflammatory Monocytes and Macrophages in Systemic Lupus Erythematosus.

bioRxiv : the preprint server for biology·2026
Same author

MIF-mediated reprogramming of myeloid lineage within the glioma tumor microenvironment impacts the efficacy of immune stimulatory gene therapy.

bioRxiv : the preprint server for biology·2026
Same author

Pathogenic role of MIF receptor (CD74) expressing T cells in inflammatory arthritis.

Proceedings of the National Academy of Sciences of the United States of America·2026

Macrophage migration inhibitory factor (MIF) is a key regulator of immune responses. Its unique structure and function present opportunities for developing novel therapies targeting inflammatory and autoimmune diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Macrophage migration inhibitory factor (MIF) is a ubiquitous protein with largely unknown functions in most cells.
  • Recent research highlights MIF as a critical upstream regulator of both innate and acquired immune responses.
  • MIF plays roles in cytokine secretion, receptor expression, p53 inhibition, and activation of signaling pathways like MAPK and Jab-1.

Purpose of the Study:

  • To explore the multifaceted roles of MIF in the immune system.
  • To investigate MIF as a potential therapeutic target for inflammatory and autoimmune conditions.
  • To identify unique structural features of MIF for drug design.

Main Methods:

  • Review of in vitro and in vivo studies on MIF function.

Related Experiment Videos

  • Analysis of MIF's regulatory effects on immune pathways.
  • Examination of MIF's structural characteristics and catalytic activity.

    • Main Results:

    • MIF is implicated in regulating cytokine secretion and immune cell receptor expression.
    • Evidence suggests MIF inhibits p53 function and activates key signaling cascades.
    • Compelling data supports MIF's role in inflammatory and autoimmune processes.

    Conclusions:

    • MIF is a significant therapeutic target for inflammatory and autoimmune diseases.
    • The intrinsic catalytic activity of MIF offers unique opportunities for inhibitor design.
    • Further research into MIF inhibitors holds promise for novel treatments.